Efficacy of emicizumab in patients with severe haemophilia A without factor VIII inhibitors in Germany

New publication based on real-life data from the smart medication eDiary:

C. Escuriola Ettingshausen, W. Eberl, H. Eichler, R. Fischer, C. Hart, K. Holstein, R. Knöfler, J. Kreutz, C. D. Kühnöl, W. A. Miesbach, C. Pfrepper, A. Rösch, U. J. Sachs, K. Trautmann-Grill, W. Mondorf

Therapeutic Advances in Hematology 2024; 15

The study evaluates emicizumab prophylaxis documented in the smart medication eDiary in patients with severe hemophilia A without factor VIII inhibitors in Germany.

The full article is available here (DOI 10.1177/20406207241295653), opens in a new tab.